This is a sequencing-risk story. If Archer clears FAA gates on time, its cash, partner set, and operating assets can compound quickly; if certification or early reliability slips, the same fixed-cost structure can turn into
dilution pressure and delay the shift from prototype narrative to recurring revenue. Regulatory permissioning is the dominant risk, with manufacturing learning curve and early uptime proof next.